Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

acadia pharmaceuticals

POPULAR ARTICLES

Pharma Market Update: Q3 2019 in Review

Pharmaceutical Investing

Pharma Market Update: Q3 2019 in Review

ACADIA Pharmaceuticals Announces Positive Top-line Results from Phase 2 CLARITY Trial

Pharmaceutical Investing

ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Exclusive License Agreement

LATEST ARTICLES

Pharmaceutical Investing

Pharmaceutical Investing

Pharmaceutical Update: Q2 2018 in Review

Pharmaceutical Investing

ACADIA Pharmaceuticals Announces FDA Approval of New Dosing Formulation and Strength for NUPLAZID (Pimavanserin)

ACADIA Pharmaceuticals Initiates Phase II Trial of Pimavanserin for Adjunctive Treatment in Patients

ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation

Biotech Investing

What are the 5 Top Holdings in the SPDR S&P Biotechnology ETF?

Biotech Investing

5 Top NASDAQ Biotech Stocks: 5 Companies Gain over 30 Percent Last Week

Latest News

Gold Rally Sparks Renewed Investor Rush Into Mining Stocks

SAGA Metals Completes Maiden Drill Program and Commences Further Geophysics at the Radar Project

Gold Rally Sparks Renewed Investor Rush Into Mining Stocks

RUA GOLD Expands High-Grade Intercepts at Depth at Auld Creek: 5.9g/t AuEq over 9m and 48.3g/t AuEq over 1.25m

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis